Literature DB >> 20677326

Androgen receptor signaling induced by supraphysiological doses of dihydrotestosterone in human peripheral blood lymphocytes.

Esther Imperlini1, Annamaria Mancini, Sara Spaziani, Domenico Martone, Andreina Alfieri, Marica Gemei, Luigi del Vecchio, Pasqualina Buono, Stefania Orrù.   

Abstract

Anabolic androgenic steroids, a class of steroid hormones related to testosterone, are natural ligands of androgen receptor (AR), a member of the nuclear receptor superfamily of ligand-activated transcription factors. AR binds specific DNA elements, known as androgen-response elements. Testosterone, the main male sexual hormone, binds AR directly and indirectly, through conversion into dihydrotestosterone (DHT), its more active metabolite. Anabolic androgenic steroids are frequently detected in the urine of doped athletes; their consumption is also growing among sport amateurs and adolescents. The effects of androgens can differ depending on the target cells and/or tissues. To gain insight into transcription activation mechanisms of AR, we investigated AR protein signaling in human peripheral blood lymphocytes treated with supraphysiological doses of DHT. We performed a comparative proteomic analysis and we identified about 30 differentially expressed proteins. At least five species contained a consensus androgen-response elements sequence in the promoter region of related coding genes. The analysis also revealed that high doses of DHT activate the drug detoxification process, could stimulate an increase in cell motility and exert a prosurvival effect rather than an apoptotic one.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20677326     DOI: 10.1002/pmic.201000079

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  8 in total

1.  Mechanisms for redox actions of nicotine and glutathione in cell culture, relevant to periodontitis.

Authors:  Federico Tinti; Mena Soory
Journal:  Sci Rep       Date:  2012-08-08       Impact factor: 4.379

2.  Antioxidant response of osteoblasts to doxycycline in an inflammatory model induced by C-reactive protein and interleukin-6.

Authors:  A Tilakaratne; Mena Soory
Journal:  Infect Disord Drug Targets       Date:  2014

3.  Differential protein expression profile in the hypothalamic GT1-7 cell line after exposure to anabolic androgenic steroids.

Authors:  Freddyson J Martínez-Rivera; Juliana Pérez-Laspiur; María E Santiago-Gascot; Abner G Alemán-Reyes; Emanuel García-Santiago; Yolanda Rodríguez-Pérez; Cristhian Calo-Guadalupe; Inelia Otero-Pagán; Roxsana N Ayala-Pagán; Magdiel Martínez; Yisel M Cantres-Rosario; Loyda M Meléndez; Jennifer L Barreto-Estrada
Journal:  PLoS One       Date:  2017-07-18       Impact factor: 3.240

Review 4.  One-Carbon Metabolism in Prostate Cancer: The Role of Androgen Signaling.

Authors:  Joshua M Corbin; Maria J Ruiz-Echevarría
Journal:  Int J Mol Sci       Date:  2016-07-27       Impact factor: 5.923

5.  Supraphysiological doses of performance enhancing anabolic-androgenic steroids exert direct toxic effects on neuron-like cells.

Authors:  John R Basile; Nada O Binmadi; Hua Zhou; Ying-Hua Yang; Antonio Paoli; Patrizia Proia
Journal:  Front Cell Neurosci       Date:  2013-05-09       Impact factor: 5.505

6.  Oxidative actions of hydrogen peroxide in human gingival and oral periosteal fibroblasts: responses to glutathione and nicotine, relevant to healing in a redox environment.

Authors:  Federico Tinti; Mena Soory
Journal:  Redox Biol       Date:  2013-12-10       Impact factor: 11.799

7.  Altered brain protein expression profiles are associated with molecular neurological dysfunction in the PKU mouse model.

Authors:  Esther Imperlini; Stefania Orrù; Claudia Corbo; Aurora Daniele; Francesco Salvatore
Journal:  J Neurochem       Date:  2014-03-24       Impact factor: 5.372

Review 8.  An intracrine view of sex steroids, immunity, and metabolic regulation.

Authors:  Katya B Rubinow
Journal:  Mol Metab       Date:  2018-03-08       Impact factor: 7.422

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.